Oct 21, 20213 minCANCER RESEARCHToripalimab joins the list of ICIs that improve efficacy when added to chemotherapy in 1L NSCLC
Sep 10, 20213 minCANCER RESEARCHIpilimumab-nivolumab combo as 2L does not improve survival for immunotherapy naive NSCLC
Jan 26, 20213 minCANCER RESEARCHIASLC 2020 World Conference on Lung Cancer: LUPER initiated trial to be presented
